Key result
Early recognition of hypertrophic cardiomyopathy in adults by primary care providers can improve quality of life and reduce the incidence of sudden cardiac death, heart failure, and stroke.
This review highlights the importance of early diagnosis and management of hypertrophic cardiomyopathy in adults to prevent sudden cardiac death and progression to heart failure.
PURPOSE: To present an overview of clinical issues related to adults with hypertrophic cardiomyopathy (HCM), their presenting symptoms, diagnosis, physical examination findings, treatment, and follow-up care. DATA SOURCES: A comprehensive search of Medline (PubMed) and CINAHL was conducted using the key terms HCM, treatment, diagnosis, sudden cardiac death (SCD), and complications. This search yielded 21 articles used for this article. There were three reference books used for background, diagnosis, and treatment information as well. CONCLUSIONS: Although HCM is the most prevalent genetic disorder affecting the heart, it often goes undiagnosed until midlife after patients show symptoms of myocardial remodeling. Adults with cardiomyopathy suffer SCD or adverse events such as stroke and heart failure from HCM. Early diagnosis will prevent SCD, improve quality of life, and slow patient's progression to heart failure. IMPLICATIONS FOR PRACTICE: Early recognition of HCM in adults by their primary care providers will improve patients' quality of life and reduce incidence of SCD, heart failure, and stroke.
No takes yet. Share an insight, caveat, or question.
C. Jacobs (2014) conducted a review in Hypertrophic cardiomyopathy. Early diagnosis and management was evaluated. Early recognition of hypertrophic cardiomyopathy in adults by primary care providers can improve quality of life and reduce the incidence of sudden cardiac death, heart failure, and stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: